Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

Migraine sufferers in England may soon be able to access preventative drug – here’s how atogepant works

By Anna Andreou, Senior Lecturer and Director of Headache Research, Consultant clinical scientist; King's College London and Guy's and St Thomas' NHS Trust, King's College London
In one trial, atogepant was shown to reduce the number of migraine days a person had each month by 30%.The Conversation

Read complete article

© The Conversation -
Subscribe to

Follow us on ...
Facebook Twitter